Nuclera Unveils Antibody Triage Service to Accelerate AI‑Driven Antibody Discovery
Nuclera Launches Antibody Triage Service to Advance AI‑Driven Antibody Discovery – The biotech firm announced a new antibody screening platform that promises to shrink the gap between in‑silico hit generation and mammalian‑scale validation, giving enterprise R&D teams a faster, cheaper route to viable therapeutic candidates. From Silicon to Serum: What Nuclera’s Service Does Nuclera’s Antibody Triage…
